Related Experiment Video
Updated: Sep 17, 2026
A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
Published on: October 31, 2012
Improved survival and short-term outcome of inborn "micropremies"
Abstract:
Survival and significant chronic morbidity were determined by retrospective chart review for 107 inborn "micropremies." "Micropremies" are defined as appropriate-for-gestational age neonates of less than 1,001 grams and less than or equal to 28 weeks gestation. The overall survival rate for "micropremies" was 64 percent, ranging from 20 percent at 24 weeks to 83 percent at 27 weeks gestation. Race and sex are important determinants of survival in these infants. The incidence of severe, chronic morbidity in "micropremies" is relatively low. The acceptable outcome for "micropremies" supports aggressive perinatal management for fetuses as low as 24 to 25 weeks gestation. However, it is important for physicians to use current statistics from their own institutions when counseling parents and making management decisions.
Insights
Survival rates for micropremies (infants <1001g and ≤28 weeks gestation) were 64%, with outcomes supporting aggressive perinatal management from 24 weeks. Race and sex impact survival in these neonates.
Area of Science:
- Neonatalogy
- Perinatal Medicine
- Pediatric Survival Rates
Background:
- Micropremies, defined as appropriate-for-gestational age neonates under 1,001 grams and 28 weeks gestation, represent a vulnerable population.
- Understanding survival and morbidity in this group is crucial for optimizing perinatal care.
- Previous data may not fully reflect current outcomes for extremely premature infants.
Purpose of the Study:
- To determine survival rates and chronic morbidity in a cohort of inborn micropremies.
- To evaluate the impact of gestational age, race, and sex on outcomes.
- To inform clinical decision-making and parental counseling regarding aggressive perinatal management.
Main Methods:
- Retrospective chart review of 107 inborn micropremies.
- Data collection focused on survival status and incidence of severe, chronic morbidity.
- Analysis included stratification by gestational age, race, and sex.
Main Results:
- Overall survival rate for micropremies was 64%.
- Survival varied significantly by gestational age, from 20% at 24 weeks to 83% at 27 weeks.
- Severe, chronic morbidity incidence was relatively low, and race and sex were identified as significant determinants of survival.
Conclusions:
- The acceptable outcomes for micropremies support considering aggressive perinatal management for fetuses as early as 24 to 25 weeks gestation.
- Physicians should utilize institutional-specific statistics for accurate parental counseling and management decisions.
- Further research may explore specific interventions to improve survival and reduce morbidity in this population.
